Journal article
Age of human papillomavirus vaccination?
Evidence is overwhelming to show that prophylactic human papillomavirus (HPV) vaccines are very safe and highly efficacious in the prevention of HPV infections and related cervical precancerous lesions detected by cytology in clinical trials and HPV-vaccinated populations. These precancerous lesions, when detected by cytology and treated in a timely manner, have been credited with reductions in cervical cancer incidence and mortality. Thus, it is simply a matter of time before HPV vaccination will be shown to reduce cervical cancer and other HPV-related cancers.
Authors
Languages
- English
Publication year
2016
Journal
The Lancet Infectious Diseases
Volume
10
Type
Journal article
Categories
- Service delivery
Tags
- Coverage monitoring
- New vaccine introduction
